You can find more information about mitogen-activated protein kinase phosphatase 1, putative using the following links:

Affecting Drugs
Drug Name	PubMed Articles (year of publication)
1-(4-chlorophenyl)-5-oxo-3-pyrrolidinecarboxylic acid	In silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discovery(2014)
2-((n-[(4-fluorophenyl)(2-thienyl)methyl]glycyl)amino)-3-thiophenecarboxamide	In silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discovery(2014)
2-([n-(diphenylmethyl)glycyl]amino)-3-thiophenecarboxamide	In silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discovery(2014)
2-[(2e)-2-(1,3-benzodioxol-5-ylmethylene)hydrazino]-1h-benzimidazole	In silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discovery(2014)
2-[(2e)-2-(3,4-bi-methoxybenzylidene)hydrazino]-1h-benzimidazole	In silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discovery(2014)
3-[(e)-(1h-benzimidazol-2-ylhydrazono)methyl]-2-chloro-7-methoxyquinoline	In silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discovery(2014)
BVT 948	Antiplasmodial drug targets: a patent review (2000 - 2013)(2016)
Knockout, suggested target	In silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discovery(2014)
NSC 663,284	Antiplasmodial drug targets: a patent review (2000 - 2013)(2016)
NSC 87,877	Antiplasmodial drug targets: a patent review (2000 - 2013)(2016)
NSC 95,397	Antiplasmodial drug targets: a patent review (2000 - 2013)(2016)